Today's Daily Dose: Piroxicam

source-image
May 18, 2011
By dvm360.com staff
Untitled Document

“The potential anticancer effects of piroxicam in cats with transitional cell carcinoma have not been thoroughly described, but, anecdoctally, piroxicam appears to be well-tolerated at a dosage of 0.3 mg/kg by mouth two or three times a week. Using this dosing scheme in cats with transitional cell carcinoma should be safe based on prior pharmacokinetic studies of oral piroxicam conducted in healthy cats; however, its anticancer effectiveness remains poorly characterized in cancer-bearing cats.”

—Timothy M. Fan, DVM, PhD, DACVIM (internal medicine and oncology)

From Just Ask the Expert: Transitional cell carcinoma of the bladder and piroxicam